CVS vs CI
CVS and CI side by side — valuation & fundamentals (public data).
Key statistics
| Metric | CVSCVS HEALTH Corp | CIThe Cigna Group |
|---|---|---|
| Market cap | $133.24B | $73.73B |
| P/E (TTM) | 45.8 | 11.5 |
| P/B | 1.72 | 1.73 |
| P/S | 0.3x | 0.3x |
| Dividend yield | 2.55% | 2.18% |
| Revenue | $407.90B(TTM) | $282.38B(TTM) |
| Revenue growth (YoY) | 7.8% | 11.2% |
| Net income | $2.93B(TTM) | $6.42B(TTM) |
| Earnings growth (YoY) | -61.7% | 73.5% |
| EPS, diluted | $2.28(TTM) | $24.18(TTM) |
| EBIT margin | 1.2% | 3.3% |
| ROE | 2.3% | 14.0% |
| ROIC | 2.9% | 9.5% |
| Piotroski F | 6/9 | — |
| 1y total return | +72.4% | +7.0% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: CVS frente a CI
| Métrica | CVS | CI |
|---|---|---|
| Valor final | $13.8K | $22.5K |
| Retorno total | +37.8% | +124.6% |
| CAGR | +3.1% | +8.1% |
| Volatilidad | 28.6% | 30.6% |
| Sharpe | 0.12 | 0.29 |
| Sortino | 0.16 | 0.40 |
| Caída máxima | -56.8% | -42.5% |
Basado en 2600 días de negociación comunes, 2016-03-30 → 2026-07-31 · tasa libre de riesgo 3.83% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)